-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

621. Lymphoma—Genetic/Epigenetic Biology: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, apoptosis, Biological, Follicular Lymphoma, survivorship, Animal models, cell division, Diseases, Lymphoma (any), Non-Biological, biopsy, cell regulation, Combinations, Elderly, Mantle Cell Lymphoma, Therapies, cellular interactions, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Biological Processes, DLBCL, DNA damage, white blood cells, DNA repair, immune cells, T-Cell Lymphoma, Technology and Procedures, Cell Lineage, epigenetics, Xenograft models, Lymphoid Malignancies, Study Population, Clinically relevant, genetic profiling, genomics, pharmacology, Quality Improvement , immune mechanism, inflammation, integrative -omics, molecular testing, NGS, microenvironment, RNA sequencing, multi-systemic interactions, pathogenesis, pathways, signal transduction
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Takuro Kameda, MD1, Kotaro Shide, MD, PhD1, Ayako Kamiunten, MD1*, Tahira Yuki1*, Masaaki Sekine, MD1*, Keiichi Akizuki, MD1*, Tomonori Hidaka, MD1*, Yoko Kubuki, MD, PhD1*, Midori Sugiyama2*, Daisuke Morishita, PhD2* and Kazuya Shimoda, MD, PhD1

1Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
2Chordia Therapeutics Inc., FUJISAWA, Japan

Rossella Marullo, MD, PhD1, Maria Victoria Revuelta, PhD2*, Nahuel Zamponi, PhD3, Sarah C. Rutherford, MD4, Peter Martin, FRCPC, MD, MS4, Giorgio Inghirami, MD5*, John P. Leonard, MD3 and Leandro Cerchietti, MD6

1Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
2Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY
3Weill Cornell Medicine, New York, NY
4Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY
5Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
6Weill Cornell Medical College, New York, NY

Jean-Marie Michot Jr., MD1*, Valérie Camara-Clayette, PhD2*, Cyril Quivoron, PhD3*, Alina Danu, MD4*, Julien Lazarovici, MD5*, David Ghez, MD, PhD6*, Julien Rossignol, MD, PhD7*, Capucine Baldini, MD1*, Patricia Martin-Romano, MD, PhD8*, Clementine Sarkozy, MD, PhD8*, Andrea Varga, MD1*, Helene Lecourt9*, Veronique Vergé, MD9*, Sophie Cotteret, MD, PhD9*, Peggy Dartigues-Cuillères, MD10*, Christophe Massard, MD, PhD1* and Vincent Ribrag, MD9

1Gustave Roussy Cancer Campus, Villejuif, France
2INSTITUT GUSTAVE ROUSSY, Villejuif, FRA
3Gustave Roussy, INSERM U1170, Université Paris-Saclay, Villejuif, France
4Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
5Department of hematology, Gustave Roussy Cancer Campus Grand Paris, Villejuif CEDEX, France
6Service d'Hématologie, Département de Médecine, Gustave Roussy Cancer Campus, Villejuif, France
7Hematology, Gustave Roussy, Villejuif, France
8DITEP, Gustave Roussy, Villejuif, France
9Gustave Roussy, Villejuif, France
10Pathology Department, Institut Gustave Roussy, Villejuif, France

Vivian Changying Jiang, PhD1, Shaojun Zhang, PhD2*, Shuangtao Zhao, PhD2*, Yang Liu, PhD1*, Joseph McIntosh, BS1*, Linghua Wang, MD, PhD, MS2 and Michael Wang, MD1,3

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Tevfik Hatipoğlu, M.S.1,2*, Esra Esmeray, M.S.1,2*, Xiaozhou Hu, M.D.1,2*, Hongling Yuan, M.D.1,3*, Ayça Erşen Danyeli, M.D.4*, Ahmet Şeyhanlı, M.D.5*, Tuğba Önal Süzek, Ph.D.6*, Weiwei Zhang, Ph.D.7*, Aybüke Olgun, M.D.8*, Burcu Akman, M.S.1,2*, Sermin Özkal, M.D.9*, Hua You, M.D., Ph.D.10*, İnci Alacacıoğlu, M.D.11*, Mehmet Ali Özcan, M.D.11* and Can Kucuk, PhD1,2,12

1İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Turkey
2İzmir Biomedicine and Genome Center, İzmir, Turkey
3Oncology Institute, Dokuz Eylül University, İzmir, Turkey
4Department of Pathology, Acibadem University Altunizade Hospital, İstanbul, Turkey
5Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
6Department of Computer Engineering, Muğla Sıtkı Koçman University, Muğla, Turkey
7Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
8Health Sciences University İzmir Tepecik Research and Training Hospital, İzmir, TUR
9Department of Medical Pathology, Dokuz Eylül University, İzmir, Turkey
10Affiliated Cancer Hospital & Institute, Guangzhou Medical University, Guangzhou, China
11Department of Internal Medicine, Division of Hematology, Dokuz Eylül University School of Medicine, İzmir, Turkey
12Department of Medical Biology, Dokuz Eylül University, Izmir, Turkey

Jordan Krull, BS1,2, Kerstin Wenzl, PhD1, Michelle Manske, MS, BS1*, Melissa Hopper, MSc1*, Melissa C. Larson, MS3*, Vivekananda Sarangi4*, Matthew J. Maurer, MS3, Zhi-Zhang Yang, PhD1, Lisa M. Rimsza, MD5, Brian K. Link, MD6, Thomas M. Habermann, MD1, Stephen M. Ansell, MD, PhD1, Rebecca L. King, MD7, James R. Cerhan, MD, PhD1,3 and Anne J. Novak, PhD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN
3Department of Health Sciences Research, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester
5Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
6Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Ellen K. Kendall, BA1, Manishkumar S. Patel, PhD, MS, BPharm1, Sarah Ondrejka, DO2*, Agrima Mian, MBBS, MD3*, Yazeed Sawalha, MD4, Bo Hu, PhD5*, Eric D. Hsi, MD6, Brian T. Hill, MD3 and Neetu Gupta, PhD, MSc, BSc1

1Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
2Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH
3Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
4Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
5Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
6Department of Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH

Michael Y. Li, BS1,2*, Lauren C. Chong, MSc1*, Elizabeth Chavez, BSc, Cg RT1*, Bruce W Woolcock1*, Adele Telenius1*, Vivian Lam3*, Gerald Krystal, PhD3*, David W. Scott, MBChB, PhD1, Elena Viganò, PhD1, Shannon Healy, PhD1* and Christian Steidl, MD1,2

1Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
3Terry Fox Laboratory, BC Cancer, Vancouver, BC, Canada

Xiaomin Chen1,2*, Shuai Ren1,2*, Mengfei Ding, MM1,2*, Yiqing Cai1,2*, Shunfeng Hu1,2*, Yi Zhao, MM1,2*, Yang Han, MM1,2*, Xiangxiang Zhou, MD1,3* and Xin Wang, MD, PhD1,2

1Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
2Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
3Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Wei Wu, MD, PhD1,2*, Alessio Bruscaggin, PhD1, Alexandra Valera3*, Elena Flospergher, MD4*, Ferdinando Bonfiglio1*, Valeria Spina, PhD1*, Lodovico Terzi-di-Bergamo1*, Alden Moccia, M.D.5*, Riccardo Moia, MD6*, Alessia Ruffini7*, Anastasios Stathis, MD8*, Martin Faderl1*, Ricardo Koch1*, Gabriela Forestieri1*, Katia Pini1*, Adalgisa Condoluci, MD8*, Maria Cristina Pirosa8*, Bernhard Gerber8*, Silke Gillessen8*, Georg Stüssi, MD8, Michele Ghielmini8, Franco Cavalli, MD8, Stefano Luminari, MD7, Renzo Boldorini9*, Luca Mazzucchelli3*, Gianluca Gaidano10, Davide Rossi, MD, PhD1,8 and Emanuele Zucca, MD8

1Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland
2The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
3Pathology Institute, Locarno, Locarno, Switzerland
4Department of Molecular Medicine, University of Pavia, Pavia, Italy
5Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
6Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
7Hematology AUSL IRCCS Reggio Emilia, Reggio Emilia, Italy
8Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
9Pathology Department, University Hospital "Maggiore della Carità", University of Eastern Piedmont, Novara, Italy
10Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy

Manishkumar S. Patel, PhD, MS, BPharm1, Ellen K. Kendall, BA1, Sarah Ondrejka, DO2*, Agrima Mian, MBBS, MD3*, Yazeed Sawalha, MD4, Bo Hu, PhD5*, Eric D. Hsi, MD6, Brian T. Hill, MD3 and Neetu Gupta, PhD, MSc, BSc1

1Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
2Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH
3Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
4Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
5Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
6Department of Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH

*signifies non-member of ASH